We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Yesterday the CJEU handed down its decision in the eagerly awaited reference Neurim Pharmaceuticals v The Comptroller General of Patents concerning the possibility of obtaining an SPC based on a marketing authorisation ("MA"), where there has been an earlier MA for the same product but for a different use
On 28 July the ECJ handed down two rulings primarily concerning the interpretation of Article 2 of Regulation 176892 (the Supplementary Protection Certificate Regulation, now replaced by 4692009EC
The Court of Appeal in Merck v Teva has upheld the first instance decision of Floyd J., that a patent for co-formulation of medicaments for the treatment of glaucoma was invalid for obviousness
The ECJ this Tuesday handed down judgment in Case C-42808, Monsanto Technology v Cefetra, a request for a preliminary ruling on the legal protection afforded by the biotechnology Directive to genetic material
